Interaction between doxycycline and some antiepileptic drugs
- PMID: 4600204
- PMCID: PMC1610633
- DOI: 10.1136/bmj.2.5917.470
Interaction between doxycycline and some antiepileptic drugs
Abstract
The mean half life of doxycycline given to seven patients on long-term diphenylhydantoin treatment was 7.2 +/- 0.4 hours. In five patients on long-term carbamazepine treatment the half life was 8.4 +/- 1.4 hours. In four patients on combined diphenylhydantoin and carbamazepine treatment the half life was 7.4 +/- 0.7 hours. All these were significantly shorter than a mean half life of 15.1 +/- 1.0 hours when doxycycline was given to nine control patients. Therefore doxycycline in normal doses given to patients taking diphenylhydantoin or carbamazepine may fail to maintain the minimum inhibitory concentration necessary for proper bacteriostasis. When doxycycline is given in association with agents known to induce drug metabolism the serum concentration of the antibiotic should be watched to see that bacteriostatic levels are maintained.
Similar articles
-
Clinical pharmacokinetics of carbamazepine.Clin Pharmacokinet. 1978 Mar-Apr;3(2):128-43. doi: 10.2165/00003088-197803020-00003. Clin Pharmacokinet. 1978. PMID: 346287 Review.
-
Interaction between doxycycline and barbiturates.Br Med J. 1974 Mar 23;1(5907):535-6. doi: 10.1136/bmj.1.5907.535. Br Med J. 1974. PMID: 4817187 Free PMC article.
-
A double blind study of carbamazepine and diphenylhydantoin in temporal lobe epilepsy.Acta Neurol Scand Suppl. 1975;60:39-42. doi: 10.1111/j.1600-0404.1975.tb01386.x. Acta Neurol Scand Suppl. 1975. PMID: 1103551 Clinical Trial.
-
[Loading-doses of carbamazepine and diphenylhydantoin: use in high-risk patients].Arq Neuropsiquiatr. 1987 Sep;45(3):281-7. doi: 10.1590/s0004-282x1987000300008. Arq Neuropsiquiatr. 1987. PMID: 3439906 Portuguese.
-
Use of phenytoin and carbamazepine in treatment of epilepsy.Neurol Clin. 1986 Aug;4(3):585-600. Neurol Clin. 1986. PMID: 2943977 Review.
Cited by
-
Carbamazepine toxicity and poisoning. Incidence, clinical features and management.Med Toxicol Adverse Drug Exp. 1989 Mar-Apr;4(2):95-107. doi: 10.1007/BF03259906. Med Toxicol Adverse Drug Exp. 1989. PMID: 2654545 Review.
-
Clinical pharmacokinetics of carbamazepine.Clin Pharmacokinet. 1978 Mar-Apr;3(2):128-43. doi: 10.2165/00003088-197803020-00003. Clin Pharmacokinet. 1978. PMID: 346287 Review.
-
Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test.Br J Clin Pharmacol. 1998 Feb;45(2):176-8. doi: 10.1046/j.1365-2125.1998.00684.x. Br J Clin Pharmacol. 1998. PMID: 9491835 Free PMC article.
-
Pharmacokinetics of drugs used in critically ill adults.Clin Pharmacokinet. 1998 Jan;34(1):25-56. doi: 10.2165/00003088-199834010-00002. Clin Pharmacokinet. 1998. PMID: 9474472 Review.
-
Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.Drug Saf. 1998 Dec;19(6):495-510. doi: 10.2165/00002018-199819060-00006. Drug Saf. 1998. PMID: 9880092 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources